article thumbnail

A milestone for imaging in MASH diagnosis, treatment and monitoring

AuntMinnie

For those unfamiliar with steatotic liver disease, this is important because Rezdiffra is the first approved treatment for MASH, which if left untreated can progress to cirrhosis, require liver transplantation, and potentially cause death. Rajarshi Banerjee, MD, PhD.

Imaging 52
article thumbnail

GE HealthCare Announces Agreement to Acquire MIM Software

Imaging Technology

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Proscia Receives FDA Clearance for Digital Pathology Software Solution

Imaging Technology

Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. This includes MIMneuro , which offers quantification solutions for dopamine transporter imaging and amyloid imaging.

article thumbnail

InMed AI Receives FDA 510(k) clearance for NeuroShield

Imaging Technology

In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. The segmentation analysis revealed remarkable accuracy, reliability, and effectiveness of NeuroShield. Globally, over a billion people suffer from neurodegenerative disorders.

article thumbnail

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S.,

Clinic 65
article thumbnail

GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology

Imaging Technology

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc.,